RedHill Biopharma Receives Nasdaq Minimum Bid Price Deficiency Notice
Trump takes action on pharmaceuticals! Import drugs face a maximum tax rate of 100%.
Trump fulfilled his threat by imposing a tariff of up to 100% on certain imported patented drugs. However, giants such as Merck and Eli Lilly and Co had already privately 'negotiated for exemptions.' Who will ultimately bear the brunt?
RedHill Biopharma Shareholders Approve RSU Grants and Share Capital Increase
Biliary Tract Cancer Market Is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
RedHill and Cumberland Begin Joint U.S. Commercial Launch of Talicia
RedHill Biopharma Calls March 5 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
Red Hill Confirms Deeper Copper-Gold Mineralisation at Anabama in Maiden Drill Program
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
Red Hill Uncovers Broad Broken Hill-Type Mineralisation in Maiden Drilling at Broken Hill Project
ADRs End Lower; Trident Digital Tech Holdings Ltd. Declines 13%
What's Going On With Redhill Biopharma Stock On Tuesday?
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Monday's Intraday Session
RedHill Biopharma Shares Are Trading Higher After the Company Announced Development Progress for RHB-102.
Market-Moving News for January 5th
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
RedHill Biopharma Files Pro Forma Financials After Talicia Joint Venture Deal With Cumberland
Redhill Biopharma Granted U.S. Patent #12,502,381 Titled "SERINE PROTEASE INHIBITOR FOR TREATING CORONAVIRUS INFECTION"
RedHill Biopharma Secures Up to $25 Million Standby Equity Facility With YA II PN
Redhill Biopharma | 6-K: Report of foreign private issuer (related to financial reporting)